Read/Search this Article
Abstract
N-methyl-1-(3, 4-methylenedioxyphenyl) butan-2-amine (MDP-2-MB, MBDB) is a new homologue of N-methyl-1-(3, 4-methylenedioxyphenyl) propan-2-amine (MDMA), which is strictly controlled as a narcotic. As part of our continuous survey on illegal designer drugs in the Japanese market, we found that N-methyl-4-(3, 4-methylenedioxyphenyl) butan-2-amine (MDP-3-MB, HMDMA) was being sold as MBDB. As this is the first time that HMDMA has been revealed to be in market distribution, and its physico-chemical data is thus far unreported, we describe the structure elucidation of HMDMA and comparative analysis with related compounds.
Journal
- Journal of health science [List of Volumes]
-
Journal of health science 52(6), 805-810, 2006-12-01 [Table of Contents]
The Pharmaceutical Society of Japan